David R. Savello, Ph.D.
Dr.
Savello has served on the Company’s Scientific Advisory Board since February
2004. He is a Founding Member of NDA Partners LLC, a strategic and regulatory
service company and currently serves as Senior Vice President of Development at
Xenoport, Inc. Before joining NDA partners, Dr. Savello served as
Executive Vice President and Chief Scientific Officer for the Pharmaceutical
Technologies and Services Division of Cardinal Health. Prior to joining Cardinal
Health, Dr. Savello was Senior Vice President for Drug Development at Guilford
Pharmaceuticals Inc. He also served at Glaxo Wellcome for over 11 years as both
Vice President for Drug Development and Vice President of Regulatory Affairs and
Compliance. While at Glaxo, Dr. Savello was responsible for the development and
regulatory submission and approval of a number of products including
Serevent®, Flovent®, Flonase®, Imitrex®, Epivir®,
Zofran®, and the Zantac® Rx to OTC switch. He also has held R&D
management and executive management positions at Boehringer Ingelheim and 3M
Riker Laboratories.
Dr. Savello has been active throughout his professional career in scientific and
trade associations. He was elected to the executive council for AAPS and served
as Chairman for the Pharmaceutical Technology Section. He was a member of the
Pharmaceutical Development Section of PhRMA for six years and served as Chairman
of that committee. He was also a member and was elected chairman of the
Regulatory Affairs Committee of PhRMA. Dr. Savello was a member of PhRMA’s FDA
Modernization Act Committee and worked with the Congress and FDA in developing
legislation which eventually was signed into law in 1996. Dr. Savello serves on
the Board of Directors of Panacos Pharmaceuticals and Gala Biotech. He also
serves on the Board of Advisors of A.M. Pappas and Associates and on the
Development and Regulatory Advisory Board for Nektar Therapeutics. Dr. Savello
received his Bachelor of Science degree in Pharmacy from the Massachusetts
College of Pharmacy and his M.S. and Ph.D. degrees in Pharmaceutics from the
University of Maryland School of Pharmacy.
close window